Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models

Keyphrases

• Clinical Aspects 100%
• Hepatic Metastasis 100%
• Medical Dosimetry 100%
• Transarterial Radioembolization 100%
• Dosimetry Model 100%
• Hepatocellular Carcinoma Metastasis 100%
• Aspect Model 100%
• Positron Emission Tomography/computed Tomography (PET/CT) 50%
• Liver 25%
• Tumor 25%
• Quantitative Imaging 25%
• SPECT-CT 25%
• Yttrium-90 Microspheres 25%
• Yttrium-90 25%
• Metastatic Disease 25%
• Patient Selection 25%
• Dose Distribution 25%
• Primary Disease 25%
• Brachytherapy 25%
• Dose Calculation 25%
• Liver-directed Therapy 25%
• Clinical Literature 25%
• 99mTc-macroaggregated Albumin 25%
• Patient-specific Dosimetry 25%
• 90Y PET 25%
• Absorbed Dose Rate 25%

Medicine and Dentistry

• Yttrium 90 100%
• Hepatocellular Carcinoma 100%
• Radioembolization 100%
• Metastatic Carcinoma 100%
• Clinical Feature 100%
• Dosimetry 100%
• Liver Metastasis 100%
• Microsphere 50%
• Dose Distribution 50%
• Single Photon Emission Computed Tomography-Computed Tomography 25%
• Positron Emission Tomography-Computed Tomography 25%
• Quantitative Imaging 25%
• Clinician 25%
• Tumor 25%
• Dose Calculation 25%
• Technetium-99 25%
• Patient Selection 25%
• Absorbed Dose 25%
• Brachytherapy 25%
• Albumin 25%